[삼성바이오로직스] [기재정정]주요사항보고서(타법인주식및출자증권양수결정)
10/16/2026
Company
삼성바이오로직스· 207940
SAMSUNG BIOLOGICS CO.,LTD.
Showing 38 RSS articles and DART filings mapped to this company, sorted by time.
- Market
- LISTED
- Items
- 38
2026-Q4
View on DART
[삼성바이오로직스] [기재정정]주요사항보고서(유상증자결정)
10/01/2026
2026-Q3
[삼성바이오로직스] [기재정정]주요사항보고서(타법인주식및출자증권양수결정)
08/28/2026
[삼성바이오로직스] 주요사항보고서(유상증자결정)
08/28/2026